[3-(3-nitrophenyl)-1,2,4-oxadiazol-5-yl]methanamine, 95.0%, 10g

Bis(2-((S)-4-(tert-butyl)-4,5-dihydrooxazol-2-yl)phenyl)amine, 97%, 1g

Platos de evaporación ROTILABO®, 558 ml, 5 Pieza(s)

3-(2-(4-Chlorophenoxy)-2-methylpropanoyl)thiazolidine-4-carboxylic acid, 98%, 500mg

Methyl 5-amino-3-bromo-2-methylbenzoate, 97%, 1g

1-(pyrrolidin-1-ylmethyl)cyclohexanamine, 95.0%, 5g

Tetrazolo[1,5-a]pyridine-8-carboxylic acid, 97.0%, 250mg

2-[4-(1-Methyl-1-phenylethyl)phenoxy]-acetohydrazide, 95.0%, 1g

Methyl 4,6,7,8,9,10-hexahydro-2-hydroxy-4-oxopyrido[1,2-a]azepine-1-carboxylate, 95+%, 100mg

7-Chloro-1-cyclopropyl-6-fluoro-2,3-dihydro-4(1H)-quinolinone, 95%, 1g

tert-Butyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]imidazole-1-carboxylate, 95.0%, 1g

(8-Chloroquinolin-6-yl)boronic acid, 98%, 25g

4-Bromo-3-methylbenzonitrile, 95.0%, 5g